Items tagged with HIV coinfection
Lancet Series on HIV and related infections in prisoners (post with simple image)
Mass imprisonment of drug users driving global epidemics of HIV, hepatitis, and tuberculosis.
“Towards Ending the Neglect?” DNDi releases update on its paediatric HIV programme (post with simple image)
As the International AIDS Conference kicks off in Durban, the Drugs for Neglected Diseases initiative (DNDi) has released an update on its efforts to develop optimal child-adapted antiretroviral formulations. This document details some recent progress towards its final goal of developing “4-in-1” fixed-dose combinations using the World Health Organization (WHO) recommended treatment regimen for infants and young children. DNDi’s update also discusses some promising developments for treatment for children living with both HIV and tuberculosis (TB).
TB2016 highlights efforts to strengthen the global fight against TB, the leading killer of people with HIV, at AIDS 2016 (post with simple image)
Durban, South Africa, 16 July 2016 – Urgency in efforts to address the devastating global impact of tuberculosis (TB), and opportunities to make major inroads against the infectious disease, are being featured at TB2016, a two-day conference dedicated exclusively to TB, immediately preceding the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa. Organised by the International AIDS Society (IAS), which also leads the AIDS 2016 conference, TB2016 represents a unique partnership of HIV and TB scientists and advocates, convened to build greater urgency and innovation to combat both epidemics.
Stephen Lewis' keynote talk at TB2016 in Durban (post with simple image)
Stephen Lewis’ keynote address delivered at #TB2016 Durban, South Africa, July 17, 2016.
From policy to practice: How the TB-HIV response is working (post with simple image)
A new research report from ACTION shows that while countries have taken steps in the right direction since 2014 to combat the deadly duo of TB and HIV, policy improvements have not all translated into changes at the facility level. Moreover, the burden to carry out TB-HIV activities still falls heavily on under-resourced TB programs.
New clinical practice guidelines: Treatment of drug-susceptible TB (post with simple image)
Jointly developed by the American Thoracic Society, U.S. Centers for Disease Control and Prevention and Infectious Diseases Society of America.
BRICS countries underline the imperative of advancing cooperation and action on HIV and TB (post with simple image)
GENEVA, 17 October 2016—At the close of the 2016 BRICS Summit in Goa, India, leaders of the BRICS countries (Brazil, the Russian Federation, India, China and South Africa) have underlined the imperative of advancing cooperation and action to respond to the epidemics of HIV and tuberculosis.
Eastern European and Central Asian countries unite to expand access to HIV and TB treatment (post with simple image)
Health ministers from eastern Europe and central Asia adopted on 3 November in Minsk, Belarus, a consensus statement on HIV and tuberculosis (TB) treatment for all, calling for expanded and rapidly scaled-up access to affordable, quality-assured medicines.
Get on the Fast-Track: the life-cycle approach to HIV (post with simple image)
UNAIDS announces 18.2 million people on antiretroviral therapy, but warns that 15–24 years of age is a highly dangerous time for young women
Message on World AIDS Day: Ending AIDS together (post with simple image)
01 December 2016, Geneva, Switzerland - Today is World AIDS Day, it is a moment for us to reflect on the amazing achievements we have made and the millions of lives that were saved, but also on the future needs if we want to END AIDS by 2030. On this World AIDS Day, I have just two statements to make:
Page 28 of 29 · Total posts: 0←First 27 28 29 Last→